beta-solamarine has been researched along with Carcinoma, Non-Small Cell Lung in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Han, L; Li, J; Tang, Q; Wang, R; Wang, S; Wang, X; Wu, W; Xu, M; Yang, X; Zhou, Q | 1 |
Hann, SS; Li, L; Tang, Q; Wu, J; Xiao, Q; Zheng, F | 1 |
Hann, S; Li, L; Tang, Q; Wang, Z; Wu, W; Zhang, F; Zhao, S; Zhou, Y | 1 |
Chen, Y; Hann, SS; Tang, Q; Wu, J; Yang, L; Zheng, F | 1 |
Chen, Y; Hann, SS; Tang, Q; Xiao, Q; Yang, L | 1 |
Chang, LC; Kuo, KW; Liang, CH; Sheu, HM; Shiu, LY | 1 |
6 other study(ies) available for beta-solamarine and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Solamargine enhanced gefitinib antitumor effect via regulating MALAT1/miR-141-3p/Sp1/IGFBP1 signaling pathway in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; MicroRNAs; Protein Kinase Inhibitors; RNA, Long Noncoding; Signal Transduction | 2023 |
Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Topics: A549 Cells; Animals; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Forkhead Box Protein O3; Gene Expression; Humans; Immunohistochemistry; Insulin-Like Growth Factor Binding Protein 1; Lung Neoplasms; Metformin; Mice; Mice, Nude; Phosphorylation; Promoter Regions, Genetic; RNA Interference; RNA, Small Interfering; Signal Transduction; Solanaceous Alkaloids; Sp1 Transcription Factor; STAT3 Transcription Factor; Transplantation, Heterologous | 2017 |
Targeting signal transducer and activator of transcription 3 contributes to the solamargine-inhibited growth and -induced apoptosis of human lung cancer cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p21; Humans; Lung Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Solanaceous Alkaloids; STAT3 Transcription Factor | 2014 |
Inactivation of PI3-K/Akt and reduction of SP1 and p65 expression increase the effect of solamargine on suppressing EP4 expression in human lung cancer cells.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Receptors, Prostaglandin E, EP4 Subtype; RNA, Messenger; Signal Transduction; Solanaceous Alkaloids; Sp1 Transcription Factor; Transcription Factor RelA | 2015 |
Targeting EP4 downstream c-Jun through ERK1/2-mediated reduction of DNMT1 reveals novel mechanism of solamargine-inhibited growth of lung cancer cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Feedback, Physiological; Female; Humans; Lung Neoplasms; Mice, Nude; Molecular Targeted Therapy; Phosphorylation; Proto-Oncogene Proteins c-jun; Receptors, Prostaglandin E, EP4 Subtype; Solanaceous Alkaloids | 2017 |
Solamargine upregulation of Fas, downregulation of HER2, and enhancement of cytotoxicity using epirubicin in NSCLC cells.
Topics: Antibiotics, Antineoplastic; Antigens, Neoplasm; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; DNA Topoisomerases, Type II; DNA-Binding Proteins; Down-Regulation; Drug Synergism; Epirubicin; fas Receptor; Gene Expression Regulation, Neoplastic; Genes, erbB-2; Humans; Lung Neoplasms; Poly-ADP-Ribose Binding Proteins; RNA, Messenger; Solanaceous Alkaloids; Up-Regulation | 2007 |